tirzepatide obesity nejm vs Semaglutide for – NEJM, May 2025 Relevant to endocrinology, internal medicine, cardiology, obesity medicine • Tirzepatide: −20.2% weight loss at 72 wks • Semaglutide: −13.7% • Greater waist reduction At a glance factsheet: Tirzepatide

All of this expertise, knowledge, and patient care come together to ensure the best possible patient experiences

Adults: Maintenance Treatment in ADHD A double-blind, placebo-controlled, randomized withdrawal design study (Study 9) was conducted in adults ages 18 to 55 (N=123) who had a documented diagnosis of ADHD or met DSM-IV criteria for ADHD

General anesthesia or deep sedation GLP-1 therapies, like Saxenda, slow gastric emptying, possibly increasing the risk of residual gastric contents and pulmonary aspiration in patients receiving anesthesia or deep sedation for procedures

Carrying a water bottle and setting regular reminders can help maintain consistent fluid intake throughout the day

Dou B, Zhu Z, Merkurjev E, Ke L, Chen L, Jiang J, Zhu Y, Liu J, Zhang B, Wei G-W

Recommended by endocrinologists Change needs to start from within. Dr.Jonathan Blake Mitchell Are you still hesitating